Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: A case report

As the knowledge on cancer genetic alterations progresses, it fosters the need for more personalized therapeutic intervention in modern cancer management. Recently, mutations in KRAS, BRAF, and PIK3CA genes have emerged as important mechanisms of resistance to EGFR-targeted therapy in metastatic col...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Capalbo, Carlo, Marchetti, Paolo, Coppa, Anna, Calogero, Antonella, Anastasi, Emanuela, Buffone, Amelia, Belardinilli, Francesca, Gulino, Matteo, Frati, Paola, Catalano, Carlo, Cortesi, Enrico, Giannini, Giuseppe, Gulino, Alberto
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Landes Bioscience 2014
Pynciau:
Bedside to Bench Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4100983/
https://ncbi.nlm.nih.gov/pubmed/24755613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.28878
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg